Today, some university researchers and small pharmaceutical and supplement companies are developing treatments to curb ...

IC-MPGN market growth driven by rising prevalence, emerging premium-priced therapies, and off-label treatments addressing chronic immune-related kidney damage in adult populations.Dublin, Dec. 12, ...

A haematologist shares insights into the challenges of the disease and the promise of emerging treatment options.